Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.42 |
| ▸ | BCDIN3D | Q7Z5W3 | 1/20 | 0.42 |
| ▸ | SCN4A | P35499 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11879789 | 0.82 | GBA1 (0.49) | GBA1AOC3KDM4EL3MBTL1BCDIN3D | |
| SCHEMBL18539336 | 0.82 | GBA1 (0.49) | GBA1AOC3KDM4EL3MBTL1BCDIN3D | |
| SCHEMBL23374639 | 0.81 | GRIN1 (0.55) | AOC3KDM4EL3MBTL1TAAR1ADRA2A | |
| SCHEMBL2608085 | 0.81 | DPP4 (0.46) | AOC3KDM4EL3MBTL1TAAR1ADRA2A | |
| SCHEMBL8538081 | 0.80 | GRIN1 (0.47) | AOC3BCDIN3DADRA2ALMNA | |
| SCHEMBL17091537 | 0.78 | GBA1 (0.46) | GBA1AOC3KDM4EL3MBTL1SCN4A | |
| SCHEMBL18539220 | 0.78 | GBA1 (0.46) | GBA1AOC3KDM4EL3MBTL1SCN4A | |
| SCHEMBL18539372 | 0.78 | GBA1 (0.49) | GBA1AOC3TAAR1SCN4AHIF1A | |
| SCHEMBL13673875 | 0.78 | GBA1 (0.49) | GBA1AOC3TAAR1SCN4AHIF1A | |
| SCHEMBL20525309 | 0.77 | GBA1 (0.45) | GBA1AOC3KDM4EL3MBTL1SCN4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298366-A1 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | GENZYME CORPORATION (US) | 2010-11-25 | — | — | US | disclosed |
| US-7790747-B2 | Chemokine receptor binding compounds | GENZYME CORPORATION (US) | 2010-09-07 | — | — | US | disclosed |
| US-20090099205-A1 | Chemokine receptor binding compounds | GENZYME CORPORATION | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298366-A1 | CHEMOKINE RECEPTOR BINDING COMPOUNDS | CCR5, CXCR3, CCL5 | GBA1 3301/4885AOC3 4760/4885KDM4E 4532/4885 |
| US-20090099205-A1 | Chemokine receptor binding compounds | CCR5, CXCR3, CCL5 | GBA1 3301/4885AOC3 4760/4885KDM4E 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.